Respiratory syncytial virus prophylaxis for prevention of recurrent childhood wheeze and asthma: a systematic review
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2046-4053
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Respiratory syncytial virus prophylaxis for prevention of recurrent childhood wheeze and asthma: a systematic review ; volume:9 ; number:1 ; day:25 ; month:11 ; year:2020 ; pages:1-12 ; date:12.2020
Systematic Reviews ; 9, Heft 1 (25.11.2020), 1-12, 12.2020
- Urheber
-
Quinn, Lauren Alexandra
Shields, Michael D.
Sinha, Ian
Groves, Helen E.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13643-020-01527-y
- URN
-
urn:nbn:de:101:1-2021010521063391247284
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Quinn, Lauren Alexandra
- Shields, Michael D.
- Sinha, Ian
- Groves, Helen E.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Respiratory syncytial virus prophylaxis for prevention of recurrent childhood wheeze and asthma: a protocol for a systematic review
Palivizumab for prophylaxis of respiratory syncytial virus infections in preterm neonates
Severe asthma in childhood
First versus second year respiratory syncytial virus prophylaxis in chronic lung disease (2005–2015)
Exhaled 8-isoprostane in childhood asthma
Home Management of Childhood Asthma Exacerbations
Circulating microRNAs and prediction of asthma exacerbation in childhood asthma
A cost-effectiveness analysis of respiratory syncytial virus (RSV) prophylaxis in infants in the United Kingdom /
Trends in Utilization of Outpatient Respiratory Syncytial Virus Prophylaxis with Palivizumab among Medicaid- and Commercially Insured Infants
Review of the home care programmes for respiratory syncytial virus (RSV) prophylaxis in Ireland and The Netherlands
The puzzle of immune phenotypes of childhood asthma
A critical appraisal on AIT in childhood asthma
Respiratory syncytial virus prophylaxis for prevention of recurrent childhood wheeze and asthma: a protocol for a systematic review
Palivizumab for prophylaxis of respiratory syncytial virus infections in preterm neonates
Severe asthma in childhood
First versus second year respiratory syncytial virus prophylaxis in chronic lung disease (2005–2015)
Exhaled 8-isoprostane in childhood asthma
Home Management of Childhood Asthma Exacerbations
Circulating microRNAs and prediction of asthma exacerbation in childhood asthma
A cost-effectiveness analysis of respiratory syncytial virus (RSV) prophylaxis in infants in the United Kingdom /
Trends in Utilization of Outpatient Respiratory Syncytial Virus Prophylaxis with Palivizumab among Medicaid- and Commercially Insured Infants
Review of the home care programmes for respiratory syncytial virus (RSV) prophylaxis in Ireland and The Netherlands
The puzzle of immune phenotypes of childhood asthma
A critical appraisal on AIT in childhood asthma
Respiratory syncytial virus prophylaxis for prevention of recurrent childhood wheeze and asthma: a protocol for a systematic review
Palivizumab for prophylaxis of respiratory syncytial virus infections in preterm neonates
Severe asthma in childhood
First versus second year respiratory syncytial virus prophylaxis in chronic lung disease (2005–2015)
Exhaled 8-isoprostane in childhood asthma
Home Management of Childhood Asthma Exacerbations
Circulating microRNAs and prediction of asthma exacerbation in childhood asthma
A cost-effectiveness analysis of respiratory syncytial virus (RSV) prophylaxis in infants in the United Kingdom /
Trends in Utilization of Outpatient Respiratory Syncytial Virus Prophylaxis with Palivizumab among Medicaid- and Commercially Insured Infants
Review of the home care programmes for respiratory syncytial virus (RSV) prophylaxis in Ireland and The Netherlands
The puzzle of immune phenotypes of childhood asthma